-
Position Statement Clarifies Benefits of Testosterone Therapy for Women
drugs
September 06, 2019
Testosterone can be used for postmenopausal women with hypoactive sexual desire dysfunction (HSDD) but is not recommended for other symptoms or medical conditions...
-
Respiratory virus vaccine receives breakthrough therapy designation
europeanpharmaceuticalreview
September 06, 2019
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.
-
Personalised cell therapy developer Achilles closes £100m round
pharmaceutical-technology
September 05, 2019
UK-based Achilles Therapeutics has announced the closing of its £100m Series B financing round, which was led by new investor RA Capital Management and founding investor Syncona.
-
Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina
worldpharmanews
September 02, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford...
-
Major Study Gives Women More Guidance on Hormone Therapy During Menopause
drugs
August 30, 2019
Women who receive hormone therapy to help ease menopausal symptoms have an increased risk of breast cancer, which can persist long after they stop the therapy, a new study confirms.
-
Salvage Therapy Does Not Up Survival for Progressive Myeloma
drugs
August 29, 2019
For myeloma patients with progressive disease (PD) after induction therapy, deepening of response through salvage therapy is not associated with improved progression-free or overall survival...
-
Transgender 'Conversion Therapy' Common, Potentially Harmful
drugs
August 29, 2019
More than one in 10 transgender people say they've been pressured by a professional counselor to accept their birth sex.
-
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
b3cnewswire
August 22, 2019
Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI)...
-
Pfizer Invests $500M in Gene Therapy Facility
contractpharma
August 22, 2019
The Sanford, NC site to support continuing investment in gene therapy R&D .
-
Hypoglycemia Up With Intensive Glucose-Lowering Therapy
drugs
August 20, 2019
Intensive glucose-lowering therapy is prevalent among U.S. adults with diabetes and results in hospitalizations and emergency department visits for hypoglycemia...